6th Sep 2018 10:54
LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.
The FTSE 100 pharmaceutical giant said that the acquisition is expected to "increase Shire's access to plasma in the longer term and add to its European plasma collection network".
"Plasma is essential to the manufacture of immunoglobulin therapies that help treat patients living with certain rare immunological diseases," Shire said.
Immunology is Shire's largest franchise generating USD4.4 billion in product sales in 2017.
"The acquisition of sanaplasma AG demonstrates Shire's commitment to its rapidly growing and leading Immunology business," Vice President for Global Operations for Shire BioLife Plasma Services Sue Brown said.
"The combination of sanaplasma AG's 14 plasma centres in the Czech Republic and Hungary with our more than 100 BioLife centres in the US and Austria will help us to meet the continuously growing demand for plasma-derived medicines."
Shire shares were trading down 1.3% at 4,336.50 pence each on Thursday.
Related Shares:
Shire